Quick-Glia™ Astrocytes - Human iPSC-derived Astrocytes (Autism Spectrum Disorder)
Cryopreserved human iPSC-derived astrocytes from Autism Spectrum Disorder patient
AS-SeV-AU
As low as
$1,999.00
Our proprietary transcription factor-based stem cell differentiation method produces highly pure populations of astrocytes without a genetic footprint. Quick-Glia™ Astrocytes - Human iPSC-derived Astrocytes display typical astrocyte morphology and markers such as S100 Calcium Binding Protein β (S100β), Chondroitin Sulfate Proteoglycan 8 (CD44), Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1), and mature astrocyte marker Glial Fibrillary Acidic Protein (GFAP). When handled and maintained according to the instructions in this user guide, astrocytes are viable long-term and are suitable for a variety of characterization and neurotoxicity assays.
Short Description | Cryopreserved human iPSC-derived astrocytes from Autism Spectrum Disorder patient |
---|---|
Product Components | Cryopreserved cells and Component P |
Starting Material | iPSCs derived from peripheral blood mononuclear cells |
Product Use | This product is for research use only. It is not approved for use in humans or for therapeutic or diagnostic use. |
Storage Conditions | Frozen cells should be stored in liquid (vapor phase). The rest of the components should be stored at -20°C. |
Cell Type | Astrocytes |
Culture Type | Feeder Cell-Free |
Disease | Autism Spectrum Disorder |
Donor Sex | Female, Male |
Donor Race Ethnicity | Asian, Caucasian, not Latino |
Patient History | See Resources section for more information. |
Reprogramming Method | Episomal vector |
Induction Method | Transcription factors delivered by Sendai virus |
Growth Properties | Adherent |
Shipping Conditions | Dry ice (domestic) or liquid nitrogen (international) |
Shelf Life | 1 year |